State Action | Page 3 | Council For Citizens Against Government Waste

State Action

State Action

CCAGW Urges Minnesota SF 4410 Conferees to Oppose Price Control Measures

Conferees should strike all language related to the Prescription Drug Affordability Board and drug price controls from SF 4410. 

Ryan Lanier May 11, 2022
State Action

CCAGW Urges Florida Senate Leadership to Oppose Data Privacy

The Florida Senate should not consider any data privacy legislation in its upcoming special session.

Ryan Lanier May 6, 2022
State Action

CCAGW Urges Florida House Leadership to Oppose Data Privacy

The Florida House of Representatives should not consider any data privacy legislation in its upcoming special session.

Ryan Lanier May 6, 2022
State Action

CCAGW Urges Florida Governor Ron DeSantis to Oppose Data Privacy in Special Session

Governor DeSantis should oppose the consideration of data privacy legislation in the Legislature's upcoming special session.

Ryan Lanier May 6, 2022
State Action

CCAGW Urges Louisiana House Commerce Committee to Oppose HB 987

HB 987 will fail to achieve its objective to protect consumer privacy.

Ryan Lanier May 4, 2022
State Action

CCAGW Urges Louisiana Senate to Oppose SB 32

SB 32 would impede and restrict pharmacy audits. 

Ryan Lanier April 8, 2022
State Action

CCAGW Urges Oklahoma House of Representatives to Oppose SB 1860

SB 1860 would impose onerous regulations on pharmacy benefit management.

Ryan Lanier April 1, 2022
State Action

CCAGW Urges Rhode Island House State Government and Elections Committee to Oppose H 7917

H 7917 will fail to achieve its objective to protect consumer privacy.

Ryan Lanier March 29, 2022
State Action

CCAGW Urges Missouri Senate Leadership to Oppose HB 1677

HB 1677 would create unnecessary regulatory barriers that will undermine the effectiveness of pharmaceutical benefit managers. 

Ryan Lanier March 28, 2022
State Action

CCAGW Urges Kentucky Senate Appropriations and Revenue Committee to Oppose HB 457

HB 457 would create unnecessary regulatory barriers that will undermine the effectiveness of pharmaceutical benefit managers.

Ryan Lanier March 23, 2022
State Action

CCAGW Urges Missouri House of Representatives to Oppose HB 1677

HB 1677 would create unnecessary regulatory barriers that will undermine the effectiveness of pharmaceutical benefit managers. 

Ryan Lanier March 22, 2022
State Action

CCAGW Urges Alaska House Judiciary Committee to Oppose HB 159

HB 159 will fail to achieve its objective to protect consumer privacy.

Ryan Lanier March 17, 2022

Pages

Sign Up For Email Updates


Optional Member Code